The American Cancer Society (ACS) predicted a record 2 million additional cancer cases in 2024 in a Jan. 17 report.
While cancer mortality has decreased, breast, prostate, endometrial, pancreatic, kidney, and melanoma incidence has increased.
New forecasts are 2% higher than ACS’s 2023 estimates.
“Prostate cancer is the most rapidly increasing—by 3% per year—mostly due to advanced-stage disease diagnosis.
Colorectal cancer in adults under 55 and cervical cancer in women 30 to 44 have also increased, according to the report. HPV-related oral and liver malignancies in women have also increased.
ACS estimated based on 2006–2020 case statistics from all 50 states. Real-life cancer data beyond 2020 is unavailable.
“Modeled counts were then projected forward 4 years based on the most recent 4-year average annual percent change,” the research stated.
The new facts and statistics on 2024 “do not have information on possible COVID virus- or vaccine-related effects on cancer incidence,” Dr. Harvey Risch, Yale University epidemiology professor emeritus with cancer interests said.
Dr. Risch said ACS’s 2024 estimates may be accurate “as long as nothing much is happening in the population.”
Read the study here
